Renal artery stenosis predicts coronary artery disease in patients with hypertension

Thiago A Macedo1, Rodrigo P Pedrosa, Valeria Costa-Hong

  • 1Hypertension Unit, Cardiology Division, Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. thiago.cardio@gmail.com

Plos One
|March 22, 2013
PubMed

Insights

In hypertensive patients undergoing renal angiography, severe renal artery stenosis (RAS) is a strong predictor of severe coronary artery disease (CAD), even without angina symptoms. This suggests considering simultaneous investigation for both conditions.

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Medicine

Background:

  • Hypertension management often requires renal arteriography to diagnose renal artery stenosis (RAS).
  • Predictors and frequency of concurrent coronary artery disease (CAD) in hypertensive patients with RAS are not well-defined.
  • Current guidelines lack recommendations for investigating CAD in patients with RAS.

Purpose of the Study:

  • To determine the frequency of CAD in hypertensive patients undergoing renal angiography.
  • To identify predictors of CAD in this patient population.
  • To evaluate the association between RAS and CAD.

Main Methods:

  • Eighty-two hypertensive patients with suspected RAS underwent simultaneous renal and coronary angiography.
  • Significant stenosis was defined as ≥ 70% obstruction in either territory.
  • Logistic regression analysis was used to identify independent predictors of CAD.

Main Results:

  • Significant CAD was present in 39% of patients, and significant RAS in 39%.
  • Both significant CAD and RAS were found in 25.6% of patients.
  • RAS ≥ 70% was independently associated with CAD ≥ 70% (OR: 11.48), irrespective of angina symptoms.

Conclusions:

  • Severe RAS is a strong predictor of severe CAD in hypertensive patients referred for renal angiography.
  • Simultaneous investigation for CAD should be considered in these patients.
  • RAS may be an independent marker for CAD, even in the absence of angina.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...